Zeynep Canan ÖZDEMİR, Yeter Düzenli KAR, Aggül CANİK, Zeynep Küskü KİRAZ, Hülya ÖZEN, Özcan BÖR

The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia

The present study investigates the predictive value of procalcitonin (PCT),C-reactive protein (CRP), presepsin (PRE-SEP) and soluble-triggeringreceptor, as expressed on myeloid cells (sTREM-1) levels in bloodstreaminfections in pediatric patients with febrile neutropenia. A total of 47 episodesof febrile neutropenia that developed in 30 children with malignancy wereanalyzed in this study, while the control group comprised 27 children who hadundergone chemotherapy for malignancy (completed ≥2 years ago) withoutneutropenia, fever or drug use. Median PCT, CRP, PRE-SEP and sTREM-1 levelson admission were found to be significantly higher in the patient group than inthe control group, while in the blood cultures, the microbiological agent wasisolated in 13 (27.7%) of the 47 episodes. Median PCT and CRP levels on days1, 2 and 7 were higher in the blood culture-positive episodes than in the bloodculture-negative episodes. There was no significant difference in the PRE-SEPand sTREM-1 levels on days 1, 2 and 7 between the blood culture-positive andblood culture-negative episodes. The results of the study suggest that PRESEP and sTREM-1 are at measurable levels upon admission in children withfebrile neutropenia, but that these markers may not be appropriate for thepredicting of bloodstream infections, although CRP and PCT levels within thefirst 24 hours may serve as a guide for clinicians.

PDF

___

1. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99: 580-588.

2. Lanziotti VS, Povoa P, Soares M, Silva JR, Barbosa AP, Salluh JIF. Use of biomarkers in pediatric sepsis: Literature review. Rev Bras Ter Intensiva 2016; 28: 472-482.

3. Grunwald U, Krüger C, Westermann J, Lukowsky A, Ehlers M, Schütt C. An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. J Immunol Methods 1992; 155: 225- 232.

4. Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005; 11: 234-238.

5. Ackland GL, Prowle JR. Presepsin: Solving a soluble (CD14) problem in sepsis? Intensive Care Med 2015; 41: 351-353.

6. Koizumi Y, Shimizu K, Shigeta M, et al. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients. BMC Infect Dis 2017; 17: 27.

7. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009; 21: 38-46.

8. Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003; 170: 3812-3818.

9. Jiyong J, Tiancha H, Wei C, Huahao S. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: A metaanalysis. Intensive Care Med 2009; 35: 587-595.

10. Fioretto JR, Martin JG, Kurokawa CS, et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis and septic shock. Inflamm Res 2010; 59: 581-586.

11. Simon, L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004; 15: 206-217.

12. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitoninin febrile neutropenic patients:Review of the literature. Infection 2008; 36: 396-407.

13. Kitanovski L, Jazbec J, Hojker S, Derganc M. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/ clinical sepsis in children with febrile neutropenia: Comparison with interleukin-6, procalcitonin, and C-reactive protein. Support Care Cancer 2014; 22: 269-277.

14. Kebudi R, Devecioğlu Ö, Gürler N. Pediatrik febril nöropeni kılavuzu: Tanımlar ve tanı yöntemleri. Flora 2004; 2: 73-105.

15. Randolph AG, McCulloh RJ. Pediatric sepsis: Important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence 2014; 5: 179-189.

16. Ebihara Y, Kobayashi K, Ishida A, et al. Diagnositc performance of procalcitonin, presepsin and Creactive protein in patients with hematological malignancies. J Clin Lab Anal 2017; 31: e22147.

17. Maurice M, Nafea D, Sawy M, Soelam R, Youssef S. Usefulness of Presepsin (Soluble CD14 Subtype) as a diagnostic marker of sepsis in Egyptian patients with acute myeloid leukemia. Am J Mol Biol 2014; 4: 169- 176.

18. Koh H, Aimoto M, Katayama T, et al. Diagnostic value of levels of presepsin (soluble CD-14 subtype) in febrile neutropenia in patients with hematological disorders. J Infect Chemother 2016; 22: 466-471.

19. Urbonas V, EidukaiteA, Tamuliene I. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leukocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia. Cytokine 2013; 62: 34-37.

20. Olad E, Sedighi I, Mehrvar A, et al. Presepsin (Scd14) as a marker of serious bacterial infections in chemotherapy induced severe neutropenia. Iran J Ped 2014; 24: 715-722.

21. Arai Y, Mizugishi K, Nonomura K, Naitoh K, TakaoriKondo A, Yamashita K. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother 2015; 21: 564-569.

22. Gibot S, Le Renard PE, Bollaert PE, et al. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med 2005; 31: 594-597.

23. Rivera-Chavez FA, Minei JP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect (Larchmt) 2009; 10: 435-439.

24. Barraud D, Gibot S. Triggering receptor expressed on myeloid cell 1. Crit Care Clin 2011; 27: 265-279.

25. Jeong SJ, Song YG, Kim CO, et al. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness. Shock 2012; 37: 574-578.

26. Kwofie L, Rapoport BL, Fickl H, et al. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapyassociated febrile neutropenia: A pilot study. Ann Hematol 2012; 91: 605-611.

27. Miedema KG, de Bont ES, Elferink RF, et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer 2011; 19: 1593-1600.

28. Arzanian MT, Soltani B, Fahimızad A, Shiva F, Shamshiri AR, Karimi A. Association of serum soluble triggering receptor expressed on myeloid cells levels in malignant febrile neutropenic patients with bacteremia and fungemia. Iran J Pediatr 2011; 21: 301-306.

29. Phillips RS, Wade R, Lehrnbecher T, Stewart LA, Sutton AJ. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med 2012; 10: 6.

30. Lin SG, Hou TY, Huang DH, et al. Role of procalcitoninin the diagnosis of severe infection in pediatric patients with fever and neutropenia-a systematic review and meta-analysis. Pediatr Infect Dis J 2012; 10: e182-e188.